@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns2:C0015283 "exocytosis"; ns2:C1184743 "process"; ns2:C1522240 "process"; ns2:C4521541 "process" . rdf:predicate ns3:TRIPLE_UID:d6xcjtu8-TRIPLE-ABSTRACT-2 "inhibit" . rdf:subject ns2:C0011777 "dexamethasone" . rdfs:Triple-UID ns1:TRIPLE_UID:d6xcjtu8-TRIPLE-ABSTRACT-2 "d6xcjtu8-TRIPLE-ABSTRACT-2" . rdfs:sentence rdfs:label "In our previous basic studies, anti-allergic drugs (olopatadine, ketotifen), antibiotics (clarithromycin) and corticosteroids (hydrocortisone, dexamethasone) inhibited the process of exocytosis and showed anti-allergic drugs (olopatadine, ketotifen), antibiotics (clarithromycin) and corticosteroids (hydrocortisone, dexamethasone)'s potency as highly effective mast cell stabilizers." . rdfs:triple rdfs:label "dexamethasone ) inhibited the process of exocytosis" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:47:35.599182"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "QJCT5wtM+UYxMg/vV5IKQC1yrSLtA8ZG1Adaz21t8QBzt0AMo+k3SEQYgoOd5rTfGdPUrJc557ZhiWZoyU2+pCSEseWoi50ehkDiOhQV+kl1BAdbFCQpphwj60y+1wOoEZ2VCcoOlTMs70ia+dSBngzQbY7AROzaskg75B5v2O0="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:47:35.599182"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }